NEO1/NEO-EXT studies: Long-term muscle quantitative magnetic resonance imaging and functional efficacy in adults with late-onset Pompe disease (LOPD) on avalglucosidase alfa treatment.

MLA

Byrne, Barry, et al. “NEO1/NEO-EXT Studies: Long-Term Muscle Quantitative Magnetic Resonance Imaging and Functional Efficacy in Adults with Late-Onset Pompe Disease (LOPD) on Avalglucosidase Alfa Treatment.” Molecular Genetics & Metabolism, vol. 141, no. 2, Feb. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ymgme.2023.107783.

APA

Byrne, B., Carlier, P. G., Vissing, J., Dimachkie, M. M., Barohn, R., Kishnani, P. S., Ladha, S., Mengel, E., Sacconi, S., Trivedi, J., Young, P., Haack, K. A., Armstrong, N., Miossec, P., Thibault, N., Sparks, S., Schoser, B., & Diaz-Manera, J. (2024). NEO1/NEO-EXT studies: Long-term muscle quantitative magnetic resonance imaging and functional efficacy in adults with late-onset Pompe disease (LOPD) on avalglucosidase alfa treatment. Molecular Genetics & Metabolism, 141(2), N.PAG. https://doi.org/10.1016/j.ymgme.2023.107783

Chicago

Byrne, Barry, Pierre G. Carlier, John Vissing, Mazen M. Dimachkie, Richard Barohn, Priya S. Kishnani, Shafeeq Ladha, et al. 2024. “NEO1/NEO-EXT Studies: Long-Term Muscle Quantitative Magnetic Resonance Imaging and Functional Efficacy in Adults with Late-Onset Pompe Disease (LOPD) on Avalglucosidase Alfa Treatment.” Molecular Genetics & Metabolism 141 (2): N.PAG. doi:10.1016/j.ymgme.2023.107783.